产品介绍 评论(0)
物种
Human分子别名
Bone morphogenetic protein 7, BMP-7, Osteogenic protein 1 (OP-1), Eptotermin alfaAccession
P18075表达序列
Ser293-His431
表达宿主
HEK293分子量
15-25 kDa (Reducing)
纯度
>95% by SDS-PAGE.内毒素含量
<0.1EU/μg活性
EC50 = 54-69 ng/ml标记
Unconjugated标签
No Tag性状
Lyophilized powder缓冲体系
4mM HCl
溶解方法
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
储存条件
·12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
·3 months, -20 to -80℃ under sterile conditions after reconstitution.
·1 week, 2 to 8℃ under sterile conditions after reconstitution.
·Please avoid repeated freeze-thaw cycles.文献引用
Nat Med. 2007 Aug;13(8):952-61
Nature. 2008 Aug 21;454(7207):1000-4.
Bone Morphogenetic Protein-7 (BMP-7), also known as Osteogenic Protein-1 (OP-1), is a member of the transforming growth factor-beta (TGF-β) superfamily and plays a critical role in embryonic development, particularly in skeletal and renal organogenesis. Initially identified in 1990 through independent cloning efforts by Ozkaynak et al. and Celeste et al., BMP-7 was recognized for its potent ability to induce endochondral bone formation. The mature protein functions by binding to type I and type II serine/threonine kinase receptors, activating SMAD-dependent (e.g., SMAD1/5/8) and independent signaling pathways that regulate target genes involved in cell differentiation, apoptosis, and extracellular matrix remodeling. Beyond its osteogenic properties, research over the past two decades has revealed its crucial role as a guardian of epithelial and mesenchymal homeostasis, where it counteracts pro-fibrotic and pro-inflammatory signals, particularly those mediated by TGF-β.
生物活性
Determined by its ability to induce alkaline phosphatase production by ATDC-5 cells. The expected EC50 for this effect is 54-69 ng/ml.
电泳
2μg (R: reducing condition, N: non-reducing condition).







评论(0)